The increasing prevalence of diabetes, growing geriatric population, increasing prevalence of obesity, technological of drug delivery devices and increasing awareness of diabetic care are driving the growth of the market.
In terms of type, the insulin delivery device market is segmented into insulin pen, insulin syringe, insulin pump and others. The insulin pen segment accounted for the major market share in the global market in 2015, and the insulin pump segment is expected to witness the highest growth during 2016-2022.
Request for a sample of this research report:
Continuous checking of glucose level is needed, in order to avoid risks associated with insulin delivery devices. In insulin pumps, the glucose level is checked continuously, so as to find if the tubing or cannula is disconnected or has blocked. It may lead to ketoacidosis, due to breakdown or absorption problem, skin infection at catheter site and has higher risk of hypoglycemia.
Some of the key companies operating in the insulin delivery device market include Novo Nordisk A/S, Medtronic PLC, Abbott Laboratories, Eli Lilly and Company, Insulet Corporation, Sanofi S.A., Becton, Dickinson and Company, F. Hoffmann-La Roche Ltd., Animas Corporation, B. Braun Melsungen AG, and Ypsomed Holdings AG.
About P&S Intelligence
P&S Intelligence is a provider of market research and consulting services catering to the market information needs of burgeoning industries across the world. Providing the plinth of market intelligence, P&S as an enterprising research and consulting company, believes in providing thorough landscape analyses on the ever-changing market scenario, to empower companies to make informed decisions and base their business strategies with astuteness.
Toll-free: +1-888-778-7886 (USA/Canada)
Email: [email protected]
This post was originally published on Journalism Trends